Stock Scorecard
Stock Summary for EDAP TMS S.A. (EDAP) - $3.14 as of 9/6/2024 3:40:08 PM EST
Total Score
9 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EDAP
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EDAP
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EDAP
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EDAP
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for EDAP
Financial Details for EDAP
Company Overview |
|
---|---|
Ticker | EDAP |
Company Name | EDAP TMS S.A. |
Country | USA |
Description | EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 6/30/2024 |
Next Earnings Date | 11/7/2024 |
Stock Price History |
|
Last Day Price | 3.14 |
Last Day Price Updated | 9/6/2024 3:40:08 PM EST |
Last Day Volume | 41,675 |
Average Daily Volume | 83,171 |
52-Week High | 8.50 |
52-Week Low | 2.71 |
Last Price to 52 Week Low | 15.87% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 373.29 |
Sector PE | 80.12 |
5-Year Average PE | -26.76 |
Free Cash Flow Ratio | 0.00 |
Industry Free Cash Flow Ratio | 20.93 |
Sector Free Cash Flow Ratio | 30.42 |
Current Ratio Most Recent Quarter | 2.45 |
Total Cash Per Share | -0.81 |
Book Value Per Share Most Recent Quarter | 1.28 |
Price to Book Ratio | 2.21 |
Industry Price to Book Ratio | 4.95 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 1.88 |
Industry Price to Sales Ratio Twelve Trailing Months | 3.41 |
Sector Price to Sales Ratio Twelve Trailing Months | 6.66 |
Share Statistics |
|
Total Shares Outstanding | 37,103,800 |
Market Capitalization | 116,505,932 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 3.60% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -62.20% |
Annual Earnings Growth | -607.26% |
Reported EPS 12 Trailing Months | -0.59 |
Reported EPS Past Year | -0.30 |
Reported EPS Prior Year | -0.58 |
Net Income Twelve Trailing Months | -19,595,376 |
Net Income Past Year | -20,743,894 |
Net Income Prior Year | -2,933,000 |
Quarterly Revenue Growth YOY | 10.60% |
5-Year Revenue Growth | 8.60% |
Balance Sheet |
|
Total Cash Most Recent Quarter | -30,229,769 |
Total Cash Past Year | 43,471,000 |
Total Cash Prior Year | 63,136,000 |
Net Cash Position Most Recent Quarter | -31,485,769 |
Net Cash Position Past Year | 41,474,000 |
Long Term Debt Past Year | 1,997,000 |
Long Term Debt Prior Year | 3,587,000 |
Total Debt Most Recent Quarter | 1,256,000 |
Equity to Debt Ratio Past Year | 0.97 |
Equity to Debt Ratio Most Recent Quarter | 0.97 |
Total Stockholder Equity Past Year | 56,968,930 |
Total Stockholder Equity Prior Year | 71,632,000 |
Total Stockholder Equity Most Recent Quarter | 47,664,018 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -19,437,137 |
Free Cash Flow Per Share Twelve Trailing Months | -0.52 |
Free Cash Flow Past Year | -18,632,087 |
Free Cash Flow Prior Year | -5,207,000 |
Options |
|
Put/Call Ratio | 1.25 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.40 |
MACD Signal | -0.36 |
20-Day Bollinger Lower Band | 3.03 |
20-Day Bollinger Middle Band | 5.29 |
20-Day Bollinger Upper Band | 7.54 |
Beta | 0.42 |
RSI | 31.18 |
50-Day SMA | 5.94 |
150-Day SMA | 7.56 |
200-Day SMA | 7.33 |
System |
|
Modified | 9/6/2024 11:59:32 PM EST |